A $200 million transaction between owner Serán Bioscience and Bain Capital Life Sciences in 2024 helped support the buildout ...

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...

The "Best Practices for Supplier Qualification in Life Science Training Course (May 6th - May 7th, 2026)" has been added to ResearchAndMarkets.com's offering. Conduct thorough supplier qualifications ...

Sharp Sterile Manufacturing is investing $28 million to expand equipment at its Lee facility, a move expected to double ...

West Pharmaceutical Services, Inc. WST is well-positioned for growth, backed by a robust GLP-1-related demand and expansion ...

AbbVie to buy West Pharma’s SmartDose Tempe facility for $112.5M, expanding drug delivery manufacturing ahead of mid-2026 close.

Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.

ProMed, a leading contract manufacturer specializing in medical-grade silicone and plastic components, provides comprehensive support for medical device, pharmaceutical, and combination drug-device ...

According to MarketsandMarkets, the Pharmaceutical Filtration Consumables Market is projected to grow from about USD 11.96 billion in 2025 to ...

Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.

The Wegovy pill's approval signifies a shift from injectable to oral dosage forms, driven by patient preference for convenience and requiring advanced formulation techniques. Rapid scaling of ...

"PAI is a market leader in RTU oral liquid medicines, and that same focus on quality, reliability, and patient-centric design carries naturally into RTU injectables," said Kurt Orlofski, CEO of PAI ...